4 completed, 1 not yet recruiting. 5 Phase 1.
By phase and status
Follow Heathy Participants: new trials by email Literature Review of Heathy Participants trials Research Report on Heathy Participants
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|
An Exploratory Study of Single-Dose and Multiple-Doses IBI3042 in Healthy, Overweight, or Obese Participants
IBI3042, Placebo - Overweight, Obesity | Phase 1 | Not yet recruiting | 94 | 2026-09-02 | 2026-09-03 |
Evaluating the Safety and Pharmacokinetics of Multiple Ascending Doses of Lucid-21-302 in Healthy Adult Participants
Lucid-21-302, Placebo - Heathy Participants | Phase 1 | Completed | 16 | 2024-09-28 | 2025-03-05 |
Study to Assess the Pharmacokinetic Bioequivalence of Budesonide and Albuterol With an Alternate Propellant Compared to Current Propellant.
Treatment A (BDA MDI HFO), Treatment B (BDA MDI HFA) - Heathy Participants | Phase 1 | Completed | 66 | 2023-11-16 | 2026-05-07 |
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of AZD7503 in Japanese Healthy Participants.
AZD7053, Placebo - Heathy Participants | Phase 1 | Completed | 12 | 2023-10-25 | 2025-07-20 |
A Study to Investigate the Effect of Multiple Doses of Itraconazole on the Pharmacokinetics of PF-06700841 in Healthy Participants
PF-06700841, Itraconazole - Heathy Participants | Phase 1 | Completed | 12 | 2019-09-24 | 2020-01-30 |
Narrower conditions
Obesity (1) · Overweight (1)
Broader conditions
Body Weight (1) · Nutrition Disorders (1) · Nutritional and Metabolic Diseases (1) · Overnutrition (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1)
Interventions
Itraconazole (1) · PF-06700841 (1)
Sponsors
AstraZeneca (2) · Hongwei Jiang (1) · Huge Biopharma Australia Pty Ltd (1) · Pfizer (1)
Countries
United States (2) · Australia (1) · China (1) · Japan (1)